Skip to main content
Clinical Trials/IRCT2012101811157N1
IRCT2012101811157N1
Completed
Phase 2

The clinical trial of comparing the effect of fluvoxamine with placebo on intensity of tinnitus due to sensorineural hearing loss

orestan University of Medical Sciences, Vice chancellor for research0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Tinnitus.
Sponsor
orestan University of Medical Sciences, Vice chancellor for research
Enrollment
100
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
orestan University of Medical Sciences, Vice chancellor for research

Eligibility Criteria

Inclusion Criteria

  • The patients who suffer from sensorineural hearing loss and tinnitus / No contraindication to fluvoxamine /With a written consent form
  • Exclusion criteria: Using similar drugs / Using other medications that interact with fluvoxamine / Fluvoxamine side effects presentation

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials